KALV – KalVista Pharmaceuticals Inc
KALV — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
40.01
Margin Of Safety %
Put/Call OI Ratio
0.59
EPS Next Q Diff
EPS Last/This Y
2.94
EPS This/Next Y
1.95
Price
26.72
Target Price
28.6
Analyst Recom
2.71
Performance Q
78.08
Upside
-623.8%
Beta
-0.12
Ticker: KALV
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-04-13 | KALV | 19.57 | 0.53 | 0.10 | 30814 |
| 2026-04-14 | KALV | 20.32 | 0.53 | 0.29 | 30759 |
| 2026-04-15 | KALV | 20.85 | 0.53 | 0.07 | 30751 |
| 2026-04-20 | KALV | 20.88 | 0.02 | 0.02 | 20251 |
| 2026-04-23 | KALV | 19.07 | 0.02 | 4.85 | 20746 |
| 2026-04-24 | KALV | 19.4 | 0.03 | 0.56 | 20818 |
| 2026-04-27 | KALV | 19.18 | 0.03 | 0.00 | 21260 |
| 2026-04-28 | KALV | 19.24 | 0.03 | 0.22 | 21523 |
| 2026-04-29 | KALV | 26.69 | 0.03 | 0.87 | 21564 |
| 2026-04-30 | KALV | 26.65 | 0.25 | 0.26 | 31580 |
| 2026-05-01 | KALV | 26.66 | 0.43 | 1.38 | 26748 |
| 2026-05-04 | KALV | 26.67 | 0.52 | 0.61 | 29049 |
| 2026-05-05 | KALV | 26.71 | 0.52 | 3.40 | 29545 |
| 2026-05-06 | KALV | 26.73 | 0.56 | 0.35 | 30297 |
| 2026-05-07 | KALV | 26.7 | 0.55 | 5.35 | 31051 |
| 2026-05-08 | KALV | 26.72 | 0.56 | 999.99 | 30999 |
| 2026-05-11 | KALV | 26.7 | 0.58 | 4.77 | 31397 |
| 2026-05-12 | KALV | 26.72 | 0.59 | 33.43 | 31618 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-04-13 | KALV | 19.57 | - | - | -1.05 |
| 2026-04-14 | KALV | 20.31 | - | - | -1.05 |
| 2026-04-15 | KALV | 20.85 | - | - | -1.05 |
| 2026-04-16 | KALV | 19.55 | - | - | -1.05 |
| 2026-04-17 | KALV | 20.50 | - | - | -1.05 |
| 2026-04-20 | KALV | 20.88 | - | - | -1.05 |
| 2026-04-21 | KALV | 19.42 | - | - | -1.05 |
| 2026-04-22 | KALV | 19.57 | - | - | -1.05 |
| 2026-04-23 | KALV | 19.06 | - | - | -1.05 |
| 2026-04-24 | KALV | 19.61 | - | - | -0.95 |
| 2026-04-27 | KALV | 19.18 | - | - | -0.95 |
| 2026-04-28 | KALV | 19.24 | - | - | -0.95 |
| 2026-04-30 | KALV | 26.65 | - | - | -0.95 |
| 2026-05-01 | KALV | 26.66 | - | - | -0.95 |
| 2026-05-04 | KALV | 26.68 | - | - | -0.95 |
| 2026-05-05 | KALV | 26.72 | - | - | -0.95 |
| 2026-05-06 | KALV | 26.73 | - | - | -0.95 |
| 2026-05-07 | KALV | 26.70 | - | - | -0.95 |
| 2026-05-08 | KALV | 26.72 | - | - | -0.75 |
| 2026-05-11 | KALV | 26.71 | - | - | -0.75 |
| 2026-05-12 | KALV | 26.72 | - | - | -0.75 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-04-13 | KALV | -2.19 | 11.60 | 54.00 |
| 2026-04-14 | KALV | -2.19 | 11.60 | 54.00 |
| 2026-04-15 | KALV | -2.19 | 11.60 | 54.00 |
| 2026-04-16 | KALV | -2.19 | 11.60 | 54.00 |
| 2026-04-17 | KALV | -2.19 | 11.60 | 54.00 |
| 2026-04-20 | KALV | -2.19 | 11.71 | 54.00 |
| 2026-04-21 | KALV | -2.30 | 11.71 | 54.00 |
| 2026-04-22 | KALV | -2.30 | 11.71 | 54.00 |
| 2026-04-23 | KALV | -2.30 | 11.71 | 53.76 |
| 2026-04-24 | KALV | -2.33 | 11.71 | 53.76 |
| 2026-04-27 | KALV | -2.33 | 11.61 | 51.90 |
| 2026-04-28 | KALV | -2.33 | 11.61 | 51.90 |
| 2026-04-29 | KALV | -2.33 | 11.61 | 51.90 |
| 2026-04-30 | KALV | -2.33 | 11.61 | 51.90 |
| 2026-05-01 | KALV | -2.33 | 11.61 | 51.90 |
| 2026-05-04 | KALV | -2.33 | 13.42 | 51.90 |
| 2026-05-05 | KALV | -2.33 | 13.42 | 51.90 |
| 2026-05-06 | KALV | -2.33 | 13.42 | 51.90 |
| 2026-05-07 | KALV | -2.33 | 13.42 | 51.90 |
| 2026-05-08 | KALV | -2.33 | 13.42 | 51.90 |
| 2026-05-11 | KALV | -2.33 | 10.84 | 51.85 |
| 2026-05-12 | KALV | -2.33 | 10.84 | 40.01 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.4
Avg. EPS Est. Next Quarter
-0.24
Insider Transactions
-2.33
Institutional Transactions
10.84
Beta
-0.12
Average Sales Estimate Current Quarter
39
Average Sales Estimate Next Quarter
48
Fair Value
Quality Score
29
Growth Score
23
Sentiment Score
81
Actual DrawDown %
13
Max Drawdown 5-Year %
-86
Target Price
28.6
P/E
Forward P/E
43.58
PEG
P/S
958.45
P/B
P/Free Cash Flow
EPS
-4
Average EPS Est. Cur. Y
-0.75
EPS Next Y. (Est.)
1.2
Target Price Estimates Raised
Target Price Estimates Lowered
1
Profit Margin
-14242.57
Relative Volume
0.83
Return on Equity vs Sector %
Return on Equity vs Industry %
EPS 1 7Days Diff
0.2
EPS 1 30Days Diff
0.21
EBIT Estimation
◆
KALV
Healthcare
$26.73
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
75.4
Range 1M
98.6%
Sup Dist
0.1%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
57%
EPS NY
170.2%
52W%
99.3%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+42.8% upside
Upside
+42.8%
Quality
29
KalVista Pharmaceuticals, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 275
KalVista Pharmaceuticals, Inc., a biopharmaceutical company, develops oral therapies for individuals for rare diseases with unmet needs. Its lead product candidate is EKTERLY, a fast-acting potent inhibitor of plasma kallikrein for the treatment of acute attacks of hereditary angioedema (HAE). The company is also developing is developing an orally disintegrating tablet formulation; KONFIDENT-KID for pediatric use with HAE; KONFIDENT; and KONFIDENT-S to evaluate sebetralstat and ODT formulation in adolescent and adult patients. KalVista Pharmaceuticals, Inc. is headquartered in Framingham, Massachusetts.
KALV
Latest News
—
Caricamento notizie per KALV…
stock quote shares KALV – KalVista Pharmaceuticals Inc Stock Price stock today
news today KALV – KalVista Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch KALV – KalVista Pharmaceuticals Inc yahoo finance google finance
stock history KALV – KalVista Pharmaceuticals Inc invest stock market
stock prices KALV premarket after hours
ticker KALV fair value insiders trading